Investigating the preventive effect of gentamicin-lock and ethanol-lock in central venous catheter infection in children admitted to the pediatric intensive care unit.
Investigating the effect of lock therapy in reducing central venous catheter infection in patients admitted to the pediatric special care unit
Design
Clinical trial with control group, with parallel groups, single-blind, randomized, phase 2 on 228 patients. Randomaize.com was used for randomization.
Settings and conduct
Patients are divided into three groups and in an interventional way, in one group ethanol, in one group gentamicin to smear the catheter path as lock therapy and in the third group, as a control group, no drug is used to smear the catheter path.
Gentamicin with a volume of 0.25 cc (10 mg) is mixed with 9.75 cc of normal saline (ideally 1 mg in 1 cc) with a total volume of 10 cc. We inject the contents of the syringe of 5 cc of normal saline into the lumen and then aspirate. After the blood returns, the amount aspirated in the syringe is equivalent to the volume required to seal the lumen. Lock therapy is performed once a day in each line and continues for 7 days.
In the case of ethanol, 70% alcohol is used. The volume of 0.2 cc is used to fill the lumen and remains in each lumen of the catheter for 4 hours, and during this time, the lumen must be unused. Before and after each lock therapy with ethanol, the line is washed with 5 to 10 cc of normal saline. Lock therapy is performed once a day in each line and continues for 7 days.
Participants/Inclusion and exclusion criteria
- Children between the ages of 1 month and 18 years admitted to the pediatric intensive care unit
- Children who undergo central venous catheter implantation.
Intervention groups
Group 1: patients receiving ethanol as lock therapy.
Group 2: patients receiving gentamicin as lock therapy.
Main outcome variables
Prevention of infection (blood culture)
General information
Reason for update
Acronym
IRCT registration information
IRCT registration number:IRCT20221129056657N3
Registration date:2023-11-14, 1402/08/23
Registration timing:prospective
Last update:2023-11-14, 1402/08/23
Update count:0
Registration date
2023-11-14, 1402/08/23
Registrant information
Name
Gholamreza khademi
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 51 3189 1780
Email address
khademigh@mums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2023-11-21, 1402/08/30
Expected recruitment end date
2024-11-20, 1403/08/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Investigating the preventive effect of gentamicin-lock and ethanol-lock in central venous catheter infection in children admitted to the pediatric intensive care unit.
Public title
Investigating the preventive effect of ethanol and gentamicin in central venous catheter infection
Purpose
Prevention
Inclusion/Exclusion criteria
Inclusion criteria:
Children between the ages of 1 month and 18 years admitted to the pediatric intensive care unit
Children undergoing central venous catheter implantation
Exclusion criteria:
Hypersensitivity reaction to antibiotics or ethanol that is injected into the line.
Any dysfunction of the line occurs after drug injection
Age
From 1 month old to 18 years old
Gender
Both
Phase
2
Groups that have been masked
Data analyser
Sample size
Target sample size:
228
Randomization (investigator's opinion)
Randomized
Randomization description
Individual simple randomization
Random number table randomization tool using www.randomization.com
Allocation Concealment method: envelopes closed. In this method, first, a random sequence is created, then based on the size of the research sample, a number of envelopes with aluminum wrappers (in order to avoid the clarity of the contents of the envelopes), are prepared and each of the generated random sequences is recorded on a card, and the cards are inside The letter envelopes are placed in order. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of starting the registration of participants, based on the order in which eligible participants entered the study, one of the envelopes will be opened and the assigned group of that participant will be revealed.
Blinding (investigator's opinion)
Single blinded
Blinding description
For blinding, statistical consultants and data analysts were unaware of the patient's randomization and placement in the therapy group.
Placebo
Not used
Assignment
Parallel
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Committee on Ethics in Research, Faculty of Medicine, Mashhad University of Medical Sciences
Street address
Qurashi Building، Daneshgah Street,Mashhad.
City
Mashhad
Province
Razavi Khorasan
Postal code
9177897157
Approval date
2023-09-23, 1402/07/01
Ethics committee reference number
IR.MUMS.REC.1402.178
Health conditions studied
1
Description of health condition studied
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
ICD-10 code
T82.7
ICD-10 code description
Infection and inflammatory reaction due to other cardiac and vascular devices, implants and grafts
Primary outcomes
1
Description
Prevention of infection (blood culture)
Timepoint
Seven days after the start of the intervention
Method of measurement
Bactec automatic blood culture machine
Secondary outcomes
1
Description
Duration of stay in PICU
Timepoint
The time of discharge of the patient from the intensive care unit
Method of measurement
Use of checklists and patient records
Intervention groups
1
Description
Intervention group: Gentamicin with a volume of 0.25 cc (10 mg) is mixed with 9.75 cc of normal saline (ideally 1 mg in 1 cc) with a total volume of 10 cc. We inject the contents of the syringe of 5 cc of normal saline into the lumen and then aspirate. After the blood returns, the amount aspirated in the syringe is equivalent to the volume required to seal the lumen. Then that lumen is not used for 4 hours. Then the above volume is thrown away and varnish therapy is immediately performed in the other lumen. Two-lumen and three-lumen catheters will be used depending on the age and condition of the patient, and each lumen will be subjected to lock therapy separately and respectively. Lock therapy is performed once a day in each line and continues for 7 days.
Category
Prevention
2
Description
Intervention group: 70% alcohol is used. The volume of 0.2 cc is used to fill the lumen and remains in each lumen of the catheter for 4 hours, and during this time, the lumen must be unused. Two-lumen and three-lumen catheters are used depending on the age and condition of the patient. and each lumen will be subjected to lock therapy separately and in order. Before and after each lock therapy with ethanol, the line is washed with 5 to 10 cc of normal saline. Lock therapy is performed once a day in each line and continues for 7 days. From the time of catheter insertion, lock therapy starts and continues as prophylaxis, and the final result is evaluated after 7 days.
Category
Prevention
3
Description
Control group: As a control group, no drug is used to impregnate the catheter path.
Category
N/A
Recruitment centers
1
Recruitment center
Name of recruitment center
Akbar Children's Hospital
Full name of responsible person
Gholamreza Khademi
Street address
Akbar Children's Hospital, Shahid Kaveh Boulevard
City
Mashhad
Province
Razavi Khorasan
Postal code
9177897157
Phone
+98 51 3871 3801
Fax
+98 51 3870 9201
Email
khademigh@mums.ac.ir
Web page address
https://akbar.mums.ac.ir/
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Mohsen Tafaghodi
Street address
3rd floor, University Research and Technology Vice-Chancellor, University of Medical Sciences, University Street, Mashhad
City
Mashhad
Province
Razavi Khorasan
Postal code
13944 -91388
Phone
+98 51 3841 1538
Email
TafaghodiM@mums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Mashhad University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic
Person responsible for general inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Gholamreza Khademi
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Akbar Children's Hospital-Shahid Kaveh Boulevard - Mashhad
City
Mashhad
Province
Razavi Khorasan
Postal code
٩١٧٧٨٩٧١۵٧
Phone
+98 51 3189 1780
Fax
Email
khademigh@mums.ac.ir
Person responsible for scientific inquiries
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Gholamreza Khademi
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Akbar Hospital, Shahid Kaveh Boulevard, Mashhad
City
Mashhad
Province
Razavi Khorasan
Postal code
9177897157
Phone
+98 51 3871 3801
Email
khademigh@mums.ac.ir
Person responsible for updating data
Contact
Name of organization / entity
Mashhad University of Medical Sciences
Full name of responsible person
Gholamreza Khademi
Position
Associate Professor
Latest degree
Subspecialist
Other areas of specialty/work
Pediatrics
Street address
Akbar Hospital, Shahid Kaveh Boulevard, Mashhad
City
Mashhad
Province
Razavi Khorasan
Postal code
9177897157
Phone
+98 51 3871 3801
Email
khademigh@mums.ac.ir
Sharing plan
Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
No - There is not a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
No - There is not a plan to make this available
Data Dictionary
Yes - There is a plan to make this available
Title and more details about the data/document
Part of the data related to the main outcomes
When the data will become available and for how long
Six months after the results are published
To whom data/document is available
Academic institutions
Under which criteria data/document could be used
For the purpose of research for the academic community
From where data/document is obtainable
Dr. Gholamreza Khademi
khademigh@mums.ac.ir
What processes are involved for a request to access data/document
The request will be sent via email to Dr. Gholamreza Khademi and correspondence will be sent about two weeks after the registration of the data request.